# Boiron Inc. – FDA 483, Jun 26, 2026

Source: https://www.keypedia.com/records/483/boiron-inc/dee8cf5f-eb18-4f37-919e-0edeaa10a160

> FDA 483 for Boiron Inc. on June 26, 2026. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Boiron Inc.
- Inspection Date: 2026-06-26
- Product Type: drugs
- Office Name: Philadelphia District Office
- Summary: During an inspection, Boiron Inc. in Newtown Square, PA, a repacker, was cited for two significant deficiencies related to their quality systems. The firm failed to document employee training for new warehouse operations and did not initiate a required change control for the relocation of its warehousing activities. These observations indicate a lack of adherence to current good manufacturing practice regulations and internal procedures.

## Related Documents

- [483 - 2021-10-25](https://www.keypedia.com/records/483/boiron-inc/3dee1892-59c6-4588-871c-7cfdcba49c42) — date: October 25, 2021

## Related Officers

- [Consumer Safety Officer](https://www.keypedia.com/people/christina-k-theodorou/3c18d958-14de-4f25-9fbd-7358205155f7)
- [Azeezat M. Lawal](https://www.keypedia.com/people/azeezat-m-lawal/6068345c-a8c8-438e-9b59-f7fc35370a59)
- [Rahi D. Patel](https://www.keypedia.com/people/rahi-d-patel/aa11c863-2b54-4b1d-afe4-fd8fa715faee)

Company: https://www.keypedia.com/companies/boiron-inc/502403cd-f15f-4cf9-8bc2-70e99a8749b4

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8